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Ultraviolet (UV) radiation has been used for decades with
great success and at a constantly increasing rate in the
management of skin diseases, becoming an essential part
of modern dermatologic therapy (Krutmann et al, 1999).
For phototherapy, irradiation devices emitting either pre-
dominantly middlewave UV (UVB, 290–315 nm) or long-
wave UV (UVA, 315–400 nm) radiation are employed. In
former years, patients were treated with broad-band UVB,
broad-band UVA, or combination regimens. Broad-band
UV phototherapy, however, is being replaced more fre-
quently by the use of irradiation devices that allow treat-
ment of patients’ skin with selected emission spectra. Two
such modalities which have their origin in European Pho-
todermatology are 311 nm UVB phototherapy (which uses
long-waveUVBradiationabove300nmrather thanbroad-
band UVB) and high-dose UVA1 therapy (which selective
employs long-wave UVA radiation above 340 nm). In
Europe, 311 nm UVB phototherapy has almost replaced
classical broad-band UVB phototherapy and has signific-
antly improved therapeutic efficacy and safety of UVB
phototherapy (van Welden et al, 1988; Krutmann et al,
1999). The constantly increasing use of UVA-1 photother-
apy has not only improved UVA phototherapy for estab-
INTRODUCTION
The prototypic skin disease showing a favorable response to UVB photo-
therapy is psoriasis. This inflammatory dermatosis is charaterized by
keratinocyte hyperproliferation. Initially it was thought that UVB photo-
therapy works through the induction of antiproliferative effects resulting
from UVB-induced DNA damage (Epstein, 1968). The number of skin
diseases responding to UVB and UVA phototherapy, however, extends
far beyond psoriasis, and the vast majority of these UV-responsive diseases
are not characterized by hyperproliferative processes, but rather are
immunologic in nature (Volc-Platzer and Ho¨nigsmann, 1995). The capa-
city of UV radiation to affect the skin immune system has been established
since the early 1970s in numerous studies (reviewed in Kripke, 1981;
Krutmann and Elmets, 1995). It is now generally believed that UVB and
UVA phototherapy exert a variety of immunomodulatory effects on
human skin and that this is of critical importance for the therapeutic
efficacy of UV phototherapy.
It should be noted that most of the immunomodulatory effects that
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lished indications such as atopic dermatitis (Krutmann
et al, 1992a, 1998; Krutmann, 1996), but has also provided
dermatologists with the opportunity to successfully treat
previouslyuntractable skindiseases, e.g., connective tissue
diseases (Stege et al, 1997; Krutmann, 1997).
These clinical developments have stimulated studies
about themechanismsbywhichUVBandUVAphotother-
apy work. The knowledge obtained from this work is an
indispensable prerequisite to make treatment decisions on
a rationale rather than an empirical basis. Modern derma-
tologic phototherapy has started to profit from this know-
ledge, and it is very likely that this development will
continue and provide dermatologists with improved
phototherapeutic modalities and regimens for established
and new indications. This review aims to provide an over-
view about current concepts of the mode of action of
dermatologic phototherapy. Special emphasis will be
given on studies that have identified previously unrecog-
nized immunosuppressive/anti-inflammatory principles
of UV phototherapy. Key words: UVA-1 phototherapy/311 nm
UVB phototherapy/photoimmunology/apoptosis/cytokine.
Journal of Investigate Dermatology Symposium Proceedings 4:70–
72, 1999
have been described thus far are not specific for a single modality. At least
under in vitro conditions, UVB or UVA radiation may have very similar
or even identical immunosuppressive consequences. The actual thera-
peutical relevance of these effects, however, is determined by the physical
properties of the type of UV radiation employed (Everett et al, 1966).
Ultraviolet B radiation mainly affects epidermal keratinocytes and Lang-
erhans cells, whereas UVA radiation can penetrate the dermal layers at
significant doses and thereby also affect dermal fibroblasts, dermal dend-
ritic cells, endothelial cells, and skin-infiltrating inflammatory cells such
as T lymphocytes, mast cells, and granulocytes. Many of these effects
have been identified by using animal models or through in vitro studies
employing cultured human skin cells. It is beyond the scope of this study
to give a state-of-the-art review of photoimmunology, which may be
found in a recent monograph (Krutmann and Elmets, 1995). The
emphasiswill insteadbeonwork in thefieldofhumanphotoimmunology
describing immunomodulatory effects of phototherapeutic relevance.
In particular, studies employing in situ techniques in order to analyze
immunomodulatory/anti-inflammatory effects that occur in the skin of
patients while they undergo phototherapy will be discussed in greater
detail. In general, photoimmunologic effects of therapeutic relevance fall
into three major categories: (i) effects on production of soluble mediators;
(ii) modulation of the expression of cell-surface associated molecules;
and (iii) the induction of apoptosis in pathogenetically relevant cells.
UVB AND UVA RADIATION EFFECTS ON SOLUBLE
MEDIATORS
Therapeutic effects induced by UVB or UVA radiation might be attrib-
uted to the induction of mediators with anti-inflammatory or immuno-
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suppressive properties (Luger and Schwarz, 1995; Morita et al, 1997a). In
vitro studies employing cultured human keratinocytes have demonstrated
that UVB, and to some extent UVA radiation, is capable of inducing
the production of cytokines, neuropeptides, and prostanoids with such
properties. For example, a keratinocyte-derived cytokine of particular
therapeutic relevance is interleukin (IL)-10, which is functionally defined
by its capacity to suppress the production of interferon (IFN)-γ by T
lymphocytes of the T helper-1-like subtype. There has been some debate
about the capacity of human keratinocytes to secrete IL-10, but recent
in vitro and in vivo studies have unambiguously demonstrated that UVB
and, in particular, UVA1 radiation have the capacity to increase signific-
antly IL-10 mRNA and protein expression in cultured normal human
keratinocytes, and that IL-10 protein expression is increased in epidermal
keratinocytes following in vivo UV irradiation of human skin (Grewe
et al, 1995, 1996). Successful phototherapy (UVA1 or UVA/UVB) of
atopic dermatitis is associated with downregulation of IFN-γ expression
in atopic eczema (Grewe et al, 1994), and this effect may at least in
part be explained by phototherapy-induced expression of IL-10 and
subsequent paracrine suppression of IFN-γ production.
Another example of a UVB- and UVA1-inducible soluble factor that
is increasingly produced by irradiated keratinocytes and that exerts anti-
inflammatory/immunosuppressive effects is the neuropeptide α-melano-
cyte-stimulating hormone (α-MSH). In vitro exposure of human ker-
atinocytes to UVB or UVA1 radiation increases the synthesis of proopi-
omelanocorticotropin-derived peptides including α-MSH (Luger and
Schwarz, 1995). α-MSH has a variety of anti-inflammatory effects [e.g.,
inhibition of IL-1 or tumor necrosis factor (TNF)-α-mediated proin-
flammatory effects] and immunosuppressive effects (e.g., inhibition of
cell-mediated immune responses). It has been proposed that UV radi-
ation-induced production of α-MSH constitutes a UV-inducible, anti-
inflammatory principle.
A third example is the UVB and UVA radiation-induced production
of prostaglandins in epidermal keratinocytes (Grewe et al, 1993). Prosta-
galandin (PG)E2 is a potent immunosuppressant that affects the expression
of costimulatory molecules on the surface of antigen presenting cells and
thereby prevents the activation of selected T cell subsets (especially Th1-
like cells). Very recent studies indicate that in addition to keratinocytes,
UV-irradiated epidermal Langerhans cells may constitute an important
cellular source for immunosuppressive prostanoids. Ultraviolet B and, in
particular, UVA-1 irradiation of human dendritic cells, markedly induced
cyclooxygenase activity and caused the production and release of signi-
ficant amounts of PGE2 and thromboxane (Grewe et al, 1999).
Ultraviolet radiation-inducible soluble factors also include cytokines
such as IL-1 or IL-6, which exert proinflammatory and thus therapeutic-
ally unfavorable effects. It is of interest, however, that successful high-
dose UVA-1 phototherapy of patients with localized scleroderma was
associated with an up to 20-fold induction of matrix metalloproteinase
(MMP)-1 expression in sclerotic skin lesions that had improved under
phototherapy (Stege et al, 1997). In these patients, skin sclerosis is due to
an increased collagen production and deposition. Phototherapy-induced
softening and disappearance of sclerotic skin lesions may thus result from
induction of the MMP-1 protease. Similar to UVB radiation, UVA-1
radiation might induce MMP-1 expression directly, but in vitro studies
employing human dermal fibroblasts indicate that UVA-1 radiation-
induced MMP-1 expression is in part caused by an autocrine mechanism
involving the UVA-1-inducible cytokines IL-1 and IL-6 (Wlascheck
et al, 1994). At least for the treatment of sclerotic skin lesions, induction
of these proinflammatory cytokines by high-dose UVA-1 phototherapy
may be beneficial rather than detrimental.
UVB AND UVA RADIATION EFFECTS ON CELL-SURFACE
RECEPTORS
Ultraviolet radiation is capable of modulating the expression and function
of adhesion molecules, cytokine and growth factor receptors (Laskin
et al, 1985; Trefzer et al, 1993; Krutmann, 1994; Grewe et al, 1997).
Accordingly, induction of the expression of the adhesion molecule inter-
cellular adhesion molecule-1 (ICAM-1) can be efficiently prevented by
exposing human keratinocytes in vitro or in vivo to UVB or UVA radiation
(Krutmann et al, 1990a, b, 1992a; Norris et al, 1990). This anti-inflam-
matory effect of UV rdiation is thought to be of central importance for
the efficacy of UV phototherapy for inflammatory skin diseases. The
ICAM-1 molecule is functionally defined by its capacity to serve as a
counter-receptor for the lymphocyte function associated antigen-1 on
the surface of leukocytes. Increased ICAM-1 expression on the surface
of epidermal keratinocytes, which is not observed in healthy human skin,
is a hallmark for inflammatory skin conditions includingpsoriasis or atopic
dermatitis and serves as a matrix to which skin-infiltrating, inflammatory
leukocytes bind (Lisby et al, 1989). Phototherapy-induced inhibition of
keratinocyte ICAM-1 upregulation might therefore prevent the main-
tenance of the inflammatory infiltrate. Very recent studies suggest that
this important anti-inflammatory effect results from the generation of
DNA photoproducts, in particular thymine dimers, in UVB-irradiated
skin (Roza et al, 1996). Ultraviolet B radiation-induced suppression of
cytokine-mediated keratinocyte ICAM-1 expression was associated with
the formation of significant numbers of thymine dimers in UVB-irradi-
ated human skin. More importantly, topical application of a DNA repair
enzyme to irradiated human skin did not only remove UVB radiation-
induced thymine dimers, but at the same time restored the capacity of
UVB-irradiated human keratinocytes to upregulate ICAM-1 expression
upon cytokine stimulation.1 These studies strongly imply that the induc-
tion of DNA photoproducts constitutes the photobiologic basis for UVB
radiation-induced anti-inflammatory effects in human skin. Whether a
similar mechanism is also reponsible for UVA radiation-induced inhibi-
tion of keratinocyte ICAM-1 expression is currently unknown. Studies
comparing UVB versus UVA1 radiation-induced gene expression in
human keratinocytes, however, indicate that the photobiologic mechan-
isms for both types of UV irradiation greatly differ. For UVA1 radiation-
induced effects, oxidative mechanisms, in particular the generation of
singlet oxgen, rather than the induction of thymine dimers, are of great
importance (Grether-Beck et al, 1996). The generation of singlet oxygen
by UVA radiation has also been shown to be of crucial relevance for the
induction of apoptosis in skin-infiltrating T cells (Morita et al, 1997b).
UVB AND UVA RADIATION-INDUCED APOPTOSIS IN
SKIN-INFILTRATING CELLS
T cells, as compared with other cell populations such as monocytes or
keratinocytes, have an increased susceptibility towards UV radiation-
induced apoptosis. Morita et al were the first to demonstrate that induc-
tion of apoptosis in skin-infiltrating T cells is the basic mechanism in
UVA phototherapy of atopic dermatitis (Morita et al, 1997b). Atopic
dermatitis may be viewed as a T cell-mediated skin disease in which
activation of T helper cells by inhalant allergens (or atopens) leads to T
cell cytokine production and the subsequent development of eczema.
This process involves an early initiation phase that is dominated by the
expression of Th2-like cytokines, which is then switched into a second,
later phase (Grewe et al, 1998). The latter is characterized by the predom-
inance of the Th1-like cytokine IFN-γ, which is responsible for the
development and maintenance of clinically apparent eczema. Successful
phototherapy of atopic dermatitis with high-dose UVA1 radiation was
associated with a marked reduction in the number of skin-infiltrating T
cells and subsequent downregulation of IFN-γ expression in lesional
atopic skin (Grewe et al, 1993). By employing a double labeling technique
to identify CD41, apoptotic T cells, Morita et al demonstrated that high-
dose UVA1 phototherapy induced apoptosis in T helper cells present in
the dermal compartment of atopic eczema. After only a few (1–3) expo-
sures of patients to single doses of 130 J UVA1 per cm2, CD41, apoptotic
T cells were present in lesional atopic skin (Morita et al, 1997b). Con-
tinuation of high-dose UVA1 phototherapy led to a gradual increase in
the number of apoptotic T helper cells and subsequent reduction of the
inflammatory infiltrate and improvement of clinical symptoms.
Induction of T cell apoptosis is not specific for UVA phototherapy
(Marks and Fox, 1991; Krueger et al, 1995; Yoo et al, 1996; Godar and
Ultraviolet, 1999). Successful UVB phototherapy of psoriatic patients
1Stege H, Roza L, Grewe M, Krutmann J: Enzyme therapy to photoprotect
human skin: Removal of cyclobutane pyrimidine dimers from ultraviolet B
irradiated human skin by exogenous photoreactivation. Submitted.
72 KRUTMANN AND MORITA JID SYMPOSIUM PROCEEDINGS
induced a reduction in the number of skin-infiltrating T cells, which was
followed by a normalization of keratinocyte morphology. In vitro UVB
irradiation induced T cell apoptosis, indicating the possibility that the
reduction of the inflammatory infiltrate may result from UVB radiation-
induced T cell apoptosis (Krueger et al, 1995). This hypothesis has
recently been proven by the demonstration of apoptotic T cells in lesional
psoriatic skin of patients undergoing UVB phototherapy. Induction of T
cell apoptosis was observed regardless of whether broad-band UVB or
311 nm UVB phototherapy was employed. It should be noted, however,
that because of its physical properties, 311 nm UVB radiation penetrates
at much higher intensities into human dermis, and T cell apoptosis
therefore did not only occur in epidermal, but also in significant numbers
of dermal T cells. This difference may at least partially explain the clinical
observation that 311 nm UVB phototherapy is superior to broad-band
UVB phototherapy for the treatment of psoriasis.
The mechanisms by which UVA1 and UVB irradiation induce T
cell apoptosis markedly differ. In general, UVA1 radiation can cause
preprogrammed cell death (early apoptosis), which is protein synthesis
independent, as well as programmed cell death (late apoptosis), which
requires de novo protein synthesis (Godar, 1996). In contrast, UVB irradi-
ation (and alsoPUVAtreatment) exclusively induce late apoptosis (Godar,
1999). By employing atopen-specific human T helper cells that have
been cloned from lesional skin of atopic dermatitis patients, Morita et al
have demonstrated that UVA1 radiation is able to cause both early and
late apoptosis and that UVA1R-induced singlet oxygen generation is the
initiating event leading to T cell apoptosis (Morita et al, 1997b). Singlet
oxygen production induced the expression of FAS-ligand molecules on
the surface of UVA1-irradiated T cells. Subsequent binding of FAS-
ligand to FAS on the same and/or neighboring T cells was then shown
to be responsible for T cell apoptosis. The key role of singlet oxygen in
eliciting early apoptosis in human T cells has recently been corroborated
in an independent study employing Jurkat cells. Ultraviolet A1 radiation/
singlet oxygenmight act onmitochondria and induce Jurkat cell apoptosis
by opening the megachannel and by decreasing the mitochondrial mem-
brane potential (Godar, 1999). The capacity to induce early apoptosis in
mammalian cells seems to be highly specific for UVA1 radiation and
singlet oxygen, respectively. From a phototherapeutic point of view,
this qualitative difference strongly suggests that UVA1 phototherapy is
superior to UVB or PUVA therapy for skin diseases in which induction
of apoptosis in pathogenetically relevant cells is of critical importance. In
order to further test this hypothesis we have recently initiated a controlled
trial comparing the efficacy of high-dose UVA1 phototherapy versus
PUVA therapy in the treatment of patients with cutaneous T cell
lymphoma.
CONCLUSIONS
There is compelling evidence that the efficacy of UVA and UVB photo-
therapy may not simply be attributed to antiproliferative effects, but most
likely involves immunomodulatory consequences, some of which have
been outlined above. It should be noted, however, that the majority of
photoimmunologic studies have been conducted either in vitro or in
animal models, whereas only recently in situ techniques have been
employed in order to monitor immunologic changes induced in the skin
of patients undergoing UV phototherapy. These studies have already
contributed to our knowledge about the mode of action of UVA and
UVB phototherapy, e.g., by identifying apoptosis as a key mechanism in
phototherapy of T cell mediated skin diseases. This progress should
prompt further interest in studies in this area of clinical research, which
might best be described as ‘‘therapeutic photoimmunology’’.
REFERENCES
Epstein JH: UVL-induced stimulation of DNA synthesis in hairless mouse epidermis. J Invest
Dermatol 52:445–448, 1968
Everett M, Yeargers E, Sayre R, Olson R: Penetration of epidermis by ultraviolet rays.
Photochem Photobiol 5:533–542, 1966
Godar DE: Preprogrammed and programmed cell death mechanisms of UV-induced
immediate and delayed apoptosis. Photochem Photobiol 63:825–830, 1996
Godar DE, Ultraviolet A: 1 radiation mediates singlet oxygen and superoxide-anion
production which trigger two different final apoptotic pathways. J Invest Dermatol 112:3–
12, 1999
Grether-Beck S, Olaizola-Horn S, Schmitt H, et al: Activation of transcription factor AP-2
mediates UVA radiation- and singlet oxygen-induced expression of the human
intercellular adhesion molecule-1 gene. Proc Natl Aacd Sci USA 93:14586–14591, 1996
Grewe M, Trefzer U, Ballhorn A, Gyufko K, Henninger HP, Krutmann J: Analysis of the
mechanism of ultraviolet B radiation induced prostaglandin E2 synthesis by human
epidermoid carcinoma cells. J Invest Dermatol 101:528–531, 1993
Grewe M, Gyufko K, Scho¨pf E, Krutmann J: Lesional expression of interferon-γ in atopic
eczema. Lancet 343:25–26, 1994
Grewe M, Gyufko K, Krutmann J: Interleukin-10 production by cultured human
keratinocytes: regulation by ultraviolet B and ultraviolet A1 radiation. J Invest Dermatol
104:3–6, 1995
Grewe M, Duvic M, Aragane Y, Schwarz T, Ullrich SE, Krutmann J: Lack of induction of
IL-10 expression in human keratinocytes. Reply. J Invest Dermatol 106:1330–1331, 1996
Grewe M, Gyufko K, Budnik A, Berneburg M, Ruzicka T, Krutmann J: Interleukin-1
receptors type I and type II are differentially regulated in human keratinocytes by
ultraviolet B radiation. J Invest Dermatol 107:865–871, 1997
Grewe M, Bruijnzeel-Koomen CAFM, Scho¨pf E, Thepen T, Langeveld-Wildschuh AG,
Ruzicka T, Krutmann J: A role for Th1 and Th2 cells in the immunopathogenesis of
atopic dermatitis. Immunol Today 19:359–361, 1998
Grewe M, Klammer M, Vogelsang K, Krutmann J: Analysis of prostanoid production by
ultraviolet (UV) irradiated human blood derived dendritic cells. Abstract. J Invest
Dermatol 112:610, 1999
Kripke ML: Immunologic mechanisms in UV radiation carcinogenesis. Adv Cancer Res 34:69–
106, 1981
Krueger JG, Wolfe JT, Nabeja RT, et al: Successful ultraviolet B treatment of psoriasis is
accompanied by a reversal of keratinocyte pathology and by selective depletion of
intraepidermal T cells. J Exp Med 182:2057–2068, 1995
Krutmann J: Regulatory interactions between epidermal cell adhesion molecules and
cytokines. In: Luger TA, Schwarz T (eds). Epidermal Growth Factors and Cytokines Marcel
Dekker, New York, 1994, pp 415–432
Krutmann J: Phototherapy for atopic dermatitis. Dermatol Ther 1:24–31, 1996
Krutmann J: High-dose UVA-1 therapy for inflammatory skin diseases. Dermatol Ther 4:123–
128, 1997
Krutmann J: Therapeutic photomedicine: Phototherapy. In: Freedberg IM, Eisen AB, Wolff
K, Austen KF, Goldsmith LA, Katz SI, FitzpatrickTB (eds). Fitzpatrick’s Dermatology in
General Medicine, 5th edn. McGraw-Hill, New York, pp 2870–2879, 1999
Krutmann J, Elmets CA (eds). Photoimmunology. Blackwell Science, Oxford, 1995
Krutmann J, Khan IU, Wallis RS, et al: The cell membrane is a major locus for ultraviolet-
B-induced alterations in accessory cells. J Clin Invest 85:1529–1536, 1990a
Krutmann J, Koeck A, Schauer E, et al: Tumor necrosis factor β and ultraviolet radiation are
potent regulators of human keratinocyte ICAM-1 expression. J Invest Dermatol 95:127–
131, 1990b
Krutmann J, Czech W, Parlow F, Trefzer U, Kapp A, Schoepf E, Luger TA: Ultraviolet
radiation effects on human keratinocyte ICAM-1 expression: UV-induced inhibition
of cytokine induced ICAM-1 mRNA expression is transient, differentially restored for
IFN-γ versus TNFα, and followed by ICAM-1 induction via a TNFα-like pathway. J
Invest Dermatol 98:923–928, 1992a
Krutmann J, Czech W, Diepgen T, Niedner R, Kapp A, Scho¨pf E: High-dose UVA1 therapy
in the treatmentofpatientswith atopic dermatitis. JAmAcadDermatol26:225–230,1992b
Krutmann J, Diepgen TL, Luger TA, et al: High-dose UVA1 therapy for atopic dermatitis:
Results of a multicenter trial. J Am Acad Dermatol 38:589–593, 1998
Laskin JD, Lee E, Yurkow EJ, Laskin DL, Gallo MA: A possible mechanism of psoralen
phototoxicity not involving direct interaction with DNA. Proc Natl Acad Sci USA
82:6158–6162, 1985
Lisby S, Ralfkier E, Rothlein R, Veijsgard GL: Intercellular adhesion molecule-1 (ICAM-1)
expression correlated to inflammation. Br J Dermatol 120:479–484, 1989
Luger TA, Schwarz T. Effects of UV light on cytokines and neuroendocrine hormones. In:
Krutmann J, Elmets CA (eds). Photoimmunology. Blackwell Science, Oxford, 1995, pp
55–76
Marks DI, Fox RM: Mechanism of photochemotherapy induced apoptotic cell death in
lymphoid cells. Biochem Cell Biol 69:754–760, 1991
Morita A, Grewe M, Ahrens C, Grether-Beck S, Ruzicka T, Krutmann J: Ultraviolet A1
radiation effects on cytokine expression in human epidermoid carcinoma cells. Photochem
Photobiol 65:630–635, 1997a
Morita A, Werfel T, Stege H, et al: Evidence that singlet oxygen-induced human T-helper
cell apoptosis is the basic mechanism of ultraviolet-A radiation phototherapy. J Exp Med
186:1763–1768, 1997b
Norris DA, Lyons B, Middleton MH, Yohn JY, Kashihara-Sawami M: Ultraviolet radiation
can either suppress or induce expression of intercellular adhesion molecule-1 (ICAM-1)
on the surface of cultured human keratinocytes. J Invest Dermatol 95:132–138, 1990
Ozawa M, Ferenci K, Kikuchi T, et al: 311 nm UVB (narrow band UVB) induces apoptosis
of T cells within psoriatic lesions. J Exp Med 189:711–718, 1999
Roza L, Stege H, Krutmann J. Role of UV-induced DNA damage in phototherapy. In:
Ho¨nigsmann H, Jori G, Young AR (eds). The Fundamental Bases of Phototherapy. OEMF
Spa, Milano, 1996, pp 145–152
Stege H, Berneburg M, Humke S, et al: High-dose ultraviolet A1 (UVA1) radiation therapy
for localized scleroderma. J Am Acad Dermatol 36:938–944, 1997
Trefzer U, Brockhaus M, Lo¨tscher H, et al: The human 55-kd tumor necrosis factor receptor
is regulated in human keratinocytes by TNFα and by ultraviolet B radiation. J Clin
Invest 92:462–470, 1993
van Welden H, Baart de Faille H, Young E, van der Leun JC: A new development in UVB
phototherapy for psoriasis. Br J Dermatol 119:11–19, 1988
Volc-Platzer B, Ho¨nigsmann H. Photoimmunology of PUVA and UVB therapy. In:
Krutmann J, Elmets CA (eds). Photoimmunology. Blackwell Science, Oxford, 1995, pp
265–273
Wlascheck M, Heinen G, Poswig A, Schwarz A, Krieg T, Scharfetter-Kochanek K: UVA-
induced autocrine stimulation of fibroblasts derived collagenase/MMP-1 by interrelated
loops of interkeukin-1 and interleukin-6. Photochem Photobiol 59:550–556, 1994
Yoo EK, Rook AH, Elenitas R, Gasparro FP, Vowels BR: Apoptosis induction by ultraviolet
light A and photochemotherapy in cutaneous T-cell lymphoma: Relevance to
mechanism of therapeutic action. J Invest Dermatol 107:235–242, 1996
